Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02653144 · ClinicalTrials.gov registry record · Phase 4

the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block

A Phase 4 study of Opioid Use, Unspecified, sponsored by Montefiore Medical Center.

Completed
Registry status
Phase 4
Development phase
105
Enrollment target
1
Study location

NCT02653144: Completed Phase 4 study of Opioid Use, Unspecified, sponsored by Montefiore Medical Center.

NCT02653144 is a Phase 4 study of Opioid Use, Unspecified that has completed, run by Montefiore Medical Center. The registered enrollment target is 105 participants, below the 216-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02653144, a Phase 4 study of Opioid Use, Unspecified, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
105 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine if perineural dexmedetomidine can provide increased prolongation of analgesia when compared to perineural dexamethasone in patients receiving regional block for shoulder surgery. If so, dexmedetomidine may serve as a superior adjunct to peripheral nerve blocks in a rapidly evolving, ambulatory-centered surgical setting.

Primary Outcome

How much opioid did patient ask for within 24 hours post op

Conditions Studied

Interventions

  • DRUG Dexamethasone
  • DRUG Dexmedetomidine
  • DRUG Ropivacaine

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2016-03
Est. Completion 2018-11-27
Phase Phase 4
Montefiore Medical Center

345 total trials

What the finished NCT02653144 record still lists

NCT02653144 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 216-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (51% lower).

The record links to 1 condition, with Opioid Use, Unspecified appearing as the primary indexed condition, and to 3 interventions - of which Dexamethasone is the first listed.

NCT02653144 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02653144 about?

NCT02653144 is a clinical study titled "the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block". The purpose of the study is to determine if perineural dexmedetomidine can provide increased prolongation of analgesia when compared to perineural dexamethasone in patients receiving regional block for shoulder surgery. If so, dexmedetomidine may serve as a superior adjunct to peripheral nerve block...

What is the current status of trial NCT02653144?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 105 participants. The study started on 2016-03. Estimated completion is 2018-11-27.

What conditions does trial NCT02653144 study?

This clinical trial studies the following conditions: Opioid Use, Unspecified.

What interventions are being tested in trial NCT02653144?

The interventions under investigation include: Dexamethasone (DRUG), Dexmedetomidine (DRUG), Ropivacaine (DRUG).

Who is sponsoring clinical trial NCT02653144?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02653144 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use, Unspecified

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02653144's enrollment target sits among peer trials

105 5th of 9 higher than 5 of 9 other Opioid Use, Unspecified trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use, Unspecified trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03372317 · 105 participants

    Tau PET in Imaging and Cognition: Healthy Adults From 55-90

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02653144, the US trial registry maintained by the National Library of Medicine. NCT02653144 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.